Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Frontal Fibrosing Alopecia
NCT03422640Phase 4Unknown
- Sponsor
- Bellevue Dermatology
- Start
- Jul 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apremilast in frontal fibrosing alopecia (FFA), sponsored by Bellevue Dermatology. Status: unknown.
02
Drugs
apremilast
03
Conditions
frontal fibrosing alopecia (FFA)
Beyond the preview
Go deeper on NCT03422640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422640.